|   | 
               
                    
                | 
          
          
           BETHESDA, 
            Maryland, November 3, 2004 -- 
            Chindex International, Inc. (NASDAQ: CHDX 
            ) a leading independent American provider of Western healthcare 
            products distribution and healthcare services in the People's Republic 
            of China, announced that it intends to release its financial results 
            for the second quarter ended September 30, 2004, on Thursday, November 
            11, 2004.  
            
             
          Chindex's 
            management will also host a conference call on Thursday, November 
            11, 2004 at 9:00 a.m. Eastern (North America time) 10:00 p.m. China 
            and Hong Kong time to discuss its financial results.  
            
             
          To 
            participate, international callers dial 706-643-0393, domestic callers 
            dial 800-451-9102 approximately 10 minutes before the conference call 
            is scheduled to begin. The pass code for the call is 2019825 
            .  
            
             
          The 
            telephone replay will be available two hours after the call at (international) 
            706-645-9291 and (domestic) 800-642-1687, pass code 2019825 
            , and continue to be available through November 18, 2004 . 
             
            
             
          About 
            Chindex International, Inc.  
             
             
          Chindex 
            is an American company operating in several healthcare sectors of 
            the Chinese marketplace, including Hong Kong. It provides representative 
            and distribution services to a number of major multinational companies 
            including Siemens AG (ultrasound systems) and Guidant (interventional 
            cardiology products including stents, balloon catheters and guide 
            wires). Its distribution channels to the retail pharmacy industry 
            in China have been developed through a relationship with a major multinational 
            cosmetics manufacturer. It also provides healthcare services through 
            the operations of its private hospital corporation in China. With 
            twenty-three years of experience, over 800 employees, and operations 
            in the United States, China and Hong Kong, the Company's strategy 
            is to expand its cross-cultural reach by providing leading edge technologies, 
            quality products and services to Greater China's professional communities. 
            Further company information may be found at the Company's websites, 
            www.chindex.com and www.unitedfamilyhospitals.com 
            .  
            
             
            
             
          Some 
            of the information in this release may contain statements regarding 
            future expectations, plans, prospects for performance of the Company 
            that constitute forward-looking statements for purposes of the safe 
            harbor provisions of The Private Securities Litigation Reform Act 
            of 1995. The Company cannot guarantee future results, levels of activity, 
            performance or achievements. The numbers discussed in this release 
            also involve risks and uncertainties. The following factors, among 
            others, could cause actual results to differ materially from those 
            described by such statements: our ability to manage our growth and 
            maintain adequate controls, the loss of services of key personnel, 
            general market conditions including inflation or foreign currency 
            fluctuations, our dependence on relationships with suppliers, the 
            timing of our revenues and fluctuations in financial performance, 
            the availability to our customers of third-party financings, product 
            liability claims and product recalls, competition, hiring and retaining 
            qualified sales and service personnel, management of inventory, relations 
            with foreign trade corporations, dependence on sub-distributors and 
            dealers, completion and opening of healthcare facilities, attracting 
            and retaining qualified physicians and other hospital personnel, regulatory 
            compliance, the cost of malpractice , our dependence on our information 
            systems, the economic policies of the Chinese government, the newness 
            and undeveloped nature of the Chinese legal system, the regulation 
            of the conversion of Chinese currency, future epidemics in China such 
            as SARS, the control over our operation by insiders, continuity of 
            relationships with existing suppliers, and those other factors contained 
            in the section titled "Risk Factors" set forth on page 7 
            of the Company's Registration Statement on Form S-1 (File No. 333-114299) 
            declared effective by the Securities and Exchange Commission on July 
            30, 2004, as well as other documents that may be filed by the Company 
            from time to time with the Securities and Exchange Commission. The 
            forward-looking statements and numbers contained herein represent 
            the judgment of the Company, as of the date of this press release, 
            and the Company disclaims any intent or obligation to update such 
            forward-looking statements to reflect any change in the Company's 
            expectations with regard thereto or any change in events, conditions, 
            circumstances on which such statements are based.  
            
             
          ### 
             
            
             
           
           
           
           
             
             
            |